메뉴 건너뛰기




Volumn 19, Issue 1, 2010, Pages 59-64

Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in Northern Denmark

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 74549212431     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0909     Document Type: Article
Times cited : (20)

References (30)
  • 1
    • 34547136957 scopus 로고    scopus 로고
    • Ries LAG, Melbert D, Krapcho M, et al, editors, Bethesda MD, National Cancer Institute;
    • Ries LAG, Melbert D, Krapcho M, et al, editors. SEER cancer statistics review, 1975-2004. Bethesda (MD): National Cancer Institute; 2007.
    • (2007) SEER cancer statistics review, 1975-2004
  • 2
    • 1342312264 scopus 로고    scopus 로고
    • Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study
    • Chang ET, Zheng T, Weir EG, et al. Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst 2004;96:305-15.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 305-315
    • Chang, E.T.1    Zheng, T.2    Weir, E.G.3
  • 4
    • 0030271387 scopus 로고    scopus 로고
    • NF-κB: Ten years after
    • Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996;87:13-20.
    • (1996) Cell , vol.87 , pp. 13-20
    • Baeuerle, P.A.1    Baltimore, D.2
  • 5
    • 0033578879 scopus 로고    scopus 로고
    • Sulindac inhibits activation of the NF-κB pathway
    • Yamamoto Y, Yin MJ, Lin KM, Gaynor RB. Sulindac inhibits activation of the NF-κB pathway. J Biol Chem 1999;274:27307-14.
    • (1999) J Biol Chem , vol.274 , pp. 27307-27314
    • Yamamoto, Y.1    Yin, M.J.2    Lin, K.M.3    Gaynor, R.B.4
  • 6
    • 0030006437 scopus 로고    scopus 로고
    • High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
    • Bargou RC, Leng C, Krappmann D, et al. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996;87:4340-7.
    • (1996) Blood , vol.87 , pp. 4340-4347
    • Bargou, R.C.1    Leng, C.2    Krappmann, D.3
  • 7
    • 0035324928 scopus 로고    scopus 로고
    • Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells
    • Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C. Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001;97:2798-807.
    • (2001) Blood , vol.97 , pp. 2798-2807
    • Hinz, M.1    Loser, P.2    Mathas, S.3    Krappmann, D.4    Dorken, B.5    Scheidereit, C.6
  • 8
    • 18844465632 scopus 로고    scopus 로고
    • Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
    • Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-9.
    • (1997) J Clin Invest , vol.100 , pp. 2961-2969
    • Bargou, R.C.1    Emmerich, F.2    Krappmann, D.3
  • 9
    • 0034744586 scopus 로고    scopus 로고
    • Characterization of NF-κB expression in Hodgkin's disease: Inhibition of constitutively expressed NF-κB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells
    • Izban KF, Ergin M, Huang Q, et al. Characterization of NF-κB expression in Hodgkin's disease: inhibition of constitutively expressed NF-κB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Mod Pathol 2001;14:297-310.
    • (2001) Mod Pathol , vol.14 , pp. 297-310
    • Izban, K.F.1    Ergin, M.2    Huang, Q.3
  • 11
    • 0032999949 scopus 로고    scopus 로고
    • The Danish National Hospital Register. A valuable source of data for modern health sciences
    • Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH, The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
    • (1999) Dan Med Bull , vol.46 , pp. 263-268
    • Andersen, T.F.1    Madsen, M.2    Jorgensen, J.3    Mellemkjoer, L.4    Olsen, J.H.5
  • 13
    • 74549159831 scopus 로고    scopus 로고
    • Available at:, Danish National Board of Health;
    • Danish National Board of Health. The Cancer Registry 2005 and 2006. Available at: http://www.sst.dk/publ/tidsskrifter/nyetal/pdf/2008/14-08.pdf. Copenhagen: Danish National Board of Health; 2008.
    • (2008) The Cancer Registry 2005 and 2006
  • 14
    • 74549210867 scopus 로고    scopus 로고
    • Use of medical databases in clinical epidemiology
    • Sørensen HT, Christensen T, Schlosser HK, Pedersen L, editors, Aarhus University Hospital;
    • Sørensen HT, Christensen T, Schlosser HK, Pedersen L, editors. Use of medical databases in clinical epidemiology. Aarhus (Denmark): Department of Clinical Epidemiology, Aarhus University Hospital; 2008.
    • (2008) Aarhus (Denmark): Department of Clinical Epidemiology
  • 15
    • 33751395235 scopus 로고    scopus 로고
    • The Danish Civil Registration System. A cohort of eight million persons
    • Pedersen CB, Gotzsche H, Møller JO, Mortensen PB, The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441-9.
    • (2006) Dan Med Bull , vol.53 , pp. 441-449
    • Pedersen, C.B.1    Gotzsche, H.2    Møller, J.O.3    Mortensen, P.B.4
  • 16
    • 0034737272 scopus 로고    scopus 로고
    • Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9.
    • Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9.
  • 17
    • 74549129623 scopus 로고    scopus 로고
    • ATC/DDD Classification
    • WHO, Geneva: WHO;
    • WHO. ATC/DDD Classification. WHO drug information, vol. 15, no. 2. Geneva: WHO; 2001. p. 84-8.
    • (2001) WHO drug information , vol.15 , Issue.2 , pp. 84-88
  • 19
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4
  • 20
    • 0026639706 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
    • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
    • (1992) J Clin Epidemiol , vol.45 , pp. 613-619
    • Deyo, R.A.1    Cherkin, D.C.2    Ciol, M.A.3
  • 21
    • 0037386804 scopus 로고    scopus 로고
    • Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives
    • Ekström K, Hjalgrim H, Brandt L, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003;48:963-70.
    • (2003) Arthritis Rheum , vol.48 , pp. 963-970
    • Ekström, K.1    Hjalgrim, H.2    Brandt, L.3
  • 22
    • 0034018580 scopus 로고    scopus 로고
    • Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions
    • Blomqvist P, Feltelius N, Ekbom A, Klareskog L. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions. J Rheumatol 2000;27:1171-7.
    • (2000) J Rheumatol , vol.27 , pp. 1171-1177
    • Blomqvist, P.1    Feltelius, N.2    Ekbom, A.3    Klareskog, L.4
  • 23
    • 0001755365 scopus 로고
    • Epidemiological evidence on the nature of Hodgkin's disease
    • MacMahon B. Epidemiological evidence on the nature of Hodgkin's disease. Cancer 1957;10:1045-54.
    • (1957) Cancer , vol.10 , pp. 1045-1054
    • MacMahon, B.1
  • 24
    • 0038605671 scopus 로고    scopus 로고
    • Risk of cancer in a large cohort of nonaspirin NSAID users: A population-based study
    • Sørensen HT, Friis S, Norgard B, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003;88:1687-92.
    • (2003) Br J Cancer , vol.88 , pp. 1687-1692
    • Sørensen, H.T.1    Friis, S.2    Norgard, B.3
  • 25
    • 0037430059 scopus 로고    scopus 로고
    • A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin
    • Friis S, Sørensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 2003;88:684-8.
    • (2003) Br J Cancer , vol.88 , pp. 684-688
    • Friis, S.1    Sørensen, H.T.2    McLaughlin, J.K.3    Johnsen, S.P.4    Blot, W.J.5    Olsen, J.H.6
  • 26
    • 33745298519 scopus 로고    scopus 로고
    • Nuclear factor-κB in cancer development and progression
    • Karin M. Nuclear factor-κB in cancer development and progression. Nature 2006;441:431-6.
    • (2006) Nature , vol.441 , pp. 431-436
    • Karin, M.1
  • 27
    • 74549223196 scopus 로고    scopus 로고
    • IARC Working Group on the Evaluation of Cancer Preventive Agents, Lyon: IARC;
    • IARC Working Group on the Evaluation of Cancer Preventive Agents. IARC handbooks of cancer prevention. Volume 1. Lyon: IARC; 1997.
    • (1997) IARC handbooks of cancer prevention , vol.1
  • 29
    • 17444454171 scopus 로고    scopus 로고
    • Upper gastrointestinal bleeding among users of NSAIDs: A population-based cohort study in Denmark
    • Mellemkjaer L, Blot WJ, Sørensen HT, et al. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 2002;53:173-81.
    • (2002) Br J Clin Pharmacol , vol.53 , pp. 173-181
    • Mellemkjaer, L.1    Blot, W.J.2    Sørensen, H.T.3
  • 30
    • 55949103124 scopus 로고    scopus 로고
    • : The epidemiology of Hodgkin lymphoma
    • Hoppe RT, Mauch PM, Armitage JO, Diehl V, Weiss LM, editors, 2nd ed. Philadelphia: Lippincott Williams & Wilkins;
    • Mueller NE, Grufferman S, Chang ET. Chapter 2: the epidemiology of Hodgkin lymphoma. In: Hoppe RT, Mauch PM, Armitage JO, Diehl V, Weiss LM, editors. Hodgkin lymphoma. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007, p. 7-23.
    • (2007) Hodgkin lymphoma , pp. 7-23
    • Mueller, N.E.1    Grufferman, S.2    Chang, E.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.